Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Using the non-VKA oral antagonists: What does the €˜real-world’ evidence tell us? – GM Conference 2016

Professor Robinson explains what ‘real-world’ evidence tell us regarding the use of non-VKA oral antagonists from The GM Conference 2016.

  Professor Thompson G Robinson is a professor of Stroke Medicine and Deputy Head of Department at the University of Leicester. Here Professor Robinson explains what €˜real-world’ evidence tell us regarding the use of non-VKA oral antagonists.

---------------------------

This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
   
New User Registration
captcha
*Required field

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy